Stock in Biogen has resumed trading after ๐Ÿ“ˆ rallying as much as 64% after a landmark decision by the Federal Drug Administration

0
56

Stock in Biogen has resumed trading after ๐Ÿ“ˆ rallying as much as 64% after a landmark decision by the Federal Drug Administration

 Stock in Biogen has resumed trading after ๐Ÿ“ˆ rallying as much as 64% after a landmark decision by the Federal Drug Administration

Source: Bloomberg Markets

Our Twitter for Quick Updates: Twitter Follow Us

LEAVE A REPLY

Please enter your comment!
Please enter your name here

20 + 19 =

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.